STEVE ELMS - 06 Jun 2023 Form 4 Insider Report for Marker Therapeutics, Inc. (MRKR)

Role
Director
Signature
/s/ Michael Loiacono, Attorney-in-Fact
Issuer symbol
MRKR
Transactions as of
06 Jun 2023
Transactions value $
$0
Form type
4
Filing time
08 Jun 2023, 21:32:52 UTC
Previous filing
08 Mar 2023
Next filing
28 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRKR Stock Option (right to buy) Award $0 +8,000 $0 8,000 06 Jun 2023 Common Stock 8,000 $1.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests on June 6, 2024, subject to the Reporting Person's continued service as a director through the vesting date.